SLABNasdaqSemiconductors & Related DevicesFiscal year ends January 2
SILICON LABORATORIES INC.
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Aug 11, 2026
$220.99−0.01 (-0.00%)
Close on Oct 19, 2026
- Market cap
- $7.34B
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
58.2%+0.5 pts over 5 years
Operating margin
-9.0%+12.0 pts over 5 years
Net margin
-8.3%
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +34.3% | -8.5% | +9.0% | +2.0% | |
| Gross profit | +46.4% | -10.7% | +9.2% | +1.8% | |
| Free cash flow | – | -16.9% | – | -3.5% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | -6.0% | |
| Return on assets | – | – | -5.2% | |
| Current ratio | 3.51 | 3.43 | 4.69 | |
| Interest coverage | 25.6× | -3.1× | -72.3× | |
| Inventory turnover | 4.9× | 3.6× | 3.3× | |
| Capex to revenue | 1.6% | 3.5% | 3.8% | |
| Diluted shares | 42M | 44M | 33M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Silicon Laboratories generated $372.44M from operations and spent $2.37B on capital expenditure, dividends and share buybacks. 5% of that went back into the business.
Generated
$372.44M
Used
$2.37B
Capital expenditure$119.05M5%Dividends$00%Share buybacks$2.25B95%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-8.3%
×Asset turnover0.63×
×Equity multiplier1.15×
=Return on equity, FY2025-6.0%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -8.3% | 0.63× | 1.15× | -6.0% |
| FY2024 | -32.7% | 0.44× | 1.16× | -16.7% |
| FY2023 | -4.4% | 0.43× | 1.38× | -2.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
5of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$64.91M
- Cash generatingOperating cash flow above zero$95.71M
- Return on assets improvedROA up on the prior year-13.2% → -5.3%
- Earnings backed by cashOperating cash flow above net income$95.71M vs -$64.91M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose6.15 → 4.69
- No dilutionShare count did not rise32M → 33M
- Gross margin improvedGross margin up on the prior year53.42% → 58.23%
- More efficientAsset turnover rose0.40 → 0.64